Equity Profile

COR

Cencora, Inc.

Health CareHealth Care Distributors$59.6B

Feb3Thu

Pre-Earnings Brief

UpcomingQ3-2026Pre-Market9:00 AM EST

Company Snapshot

Cencora, Inc. is a key player in the health care distribution sector, focusing on delivering essential medical products and services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a critical indicator of profitability and will show how well Cencora is managing costs and generating income.

N/A

Revenue Growth

Revenue growth will provide insight into the company's ability to expand its market share and meet increasing demand in the health care sector.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

COR Q3-2026 Earnings Preview

Context

Company Snapshot

Cencora, Inc. is a key player in the health care distribution sector, focusing on delivering essential medical products and services. With a market cap of $60 billion, the company plays a vital role in ensuring that health care providers have access to necessary supplies, which is increasingly important as demand for health care services continues to grow.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+3.76%

Avg Stock Reaction

-1.64%

Last Quarter Recap

In Q2-2026, Cencora reported an EPS of $4.75, slightly missing expectations, which led to a significant drop in stock price the following day. The company continues to navigate a competitive landscape in health care distribution.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic about Cencora's upcoming earnings report, especially given its historical performance of beating EPS estimates. However, recent misses have raised concerns about the sustainability of its growth.

Bull Case

If Cencora can report strong revenue growth and maintain or improve its gross margins, it could signal robust demand and operational efficiency, leading to positive investor sentiment.

Bear Case

Conversely, if the company reports another earnings miss or provides weak guidance, it could reinforce fears about its competitive position and lead to further declines in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected EPS for this quarter?

Given the company's recent earnings history, a clear EPS target will help gauge whether Cencora can regain investor confidence.

How is Cencora managing its supply chain amid industry challenges?

Supply chain efficiency is crucial for health care distributors, and any commentary on this will be closely watched by investors.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Cencora's ability to navigate supply chain challenges, which could lead to better-than-expected performance.

Supporting Evidence

Cencora has consistently beaten EPS estimates in 88% of the last quarters, indicating strong operational management.

The options market is pricing a smaller move than historical averages, suggesting potential for a larger surprise.

Recent trends in health care demand may not be fully reflected in current estimates, allowing for upside potential.

Key Risk

If the company reports an EPS above $4.80, it could challenge the current bearish sentiment and shift market perception.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Cencora can sustain its growth trajectory amid increasing competition and operational challenges.

Bull Confirmed If

A revenue growth rate of over 10% year-over-year would confirm strong demand and operational success.

Bear Confirmed If

If EPS falls below $4.50, it could indicate deeper issues with profitability and market competitiveness.

Pre-Earnings Positioning

Options Market

Implied Move

±0.94%

Historical Avg

±5.6%

Pricing cheap

The options market is pricing in a relatively small move for Cencora's stock following the earnings report, suggesting that investors are uncertain about significant changes.

Options are pricing ±0.9% while COR has averaged ±5.6% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.3%

30d HV

60.2%

Calls (13K)P/C Ratio: 0.19Puts (105K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cencora beats expectations, history suggests the stock could rise by approximately 0.61% on the first day, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a significant decline, with historical data indicating an average drop of 17.38% following earnings misses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on supply chain management and its impact on costs.
2Details on new contracts or partnerships that could drive revenue.
3Insights into market demand trends for health care products.
4Management's outlook on competitive pressures in the health care distribution space.
5Any commentary on cost management strategies and their effectiveness.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Cirrus Logic, Inc.

Company Snapshot

Cencora, Inc. is a key player in the health care distribution sector, focusing on delivering essential medical products and services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a critical indicator of profitability and will show how well Cencora is managing costs and generating income.

N/A

Revenue Growth

Revenue growth will provide insight into the company's ability to expand its market share and meet increasing demand in the health care sector.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

COR Q3-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+3.76%

Avg Stock Reaction

-1.64%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Cencora can report strong revenue growth and maintain or improve its gross margins, it could signal robust demand and operational efficiency, leading to positive investor sentiment.

Bear Case

Conversely, if the company reports another earnings miss or provides weak guidance, it could reinforce fears about its competitive position and lead to further declines in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected EPS for this quarter?

Given the company's recent earnings history, a clear EPS target will help gauge whether Cencora can regain investor confidence.

How is Cencora managing its supply chain amid industry challenges?

Supply chain efficiency is crucial for health care distributors, and any commentary on this will be closely watched by investors.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Cencora's ability to navigate supply chain challenges, which could lead to better-than-expected performance.

Supporting Evidence

Cencora has consistently beaten EPS estimates in 88% of the last quarters, indicating strong operational management.

The options market is pricing a smaller move than historical averages, suggesting potential for a larger surprise.

Recent trends in health care demand may not be fully reflected in current estimates, allowing for upside potential.

Key Risk

If the company reports an EPS above $4.80, it could challenge the current bearish sentiment and shift market perception.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Cencora can sustain its growth trajectory amid increasing competition and operational challenges.

Bull Confirmed If

A revenue growth rate of over 10% year-over-year would confirm strong demand and operational success.

Bear Confirmed If

If EPS falls below $4.50, it could indicate deeper issues with profitability and market competitiveness.

Pre-Earnings Positioning

Options Market

Implied Move

±0.94%

Historical Avg

±5.6%

Pricing cheap

The options market is pricing in a relatively small move for Cencora's stock following the earnings report, suggesting that investors are uncertain about significant changes.

Options are pricing ±0.9% while COR has averaged ±5.6% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.3%

30d HV

60.2%

Calls (13K)P/C Ratio: 0.19Puts (105K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cencora beats expectations, history suggests the stock could rise by approximately 0.61% on the first day, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a significant decline, with historical data indicating an average drop of 17.38% following earnings misses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on supply chain management and its impact on costs.
2Details on new contracts or partnerships that could drive revenue.
3Insights into market demand trends for health care products.
4Management's outlook on competitive pressures in the health care distribution space.
5Any commentary on cost management strategies and their effectiveness.